Saptalis Pharmaceutcals

Saptalis Pharmaceuticals LLC is a Limited Liability Company headquartered in Hauppauge, New York. Established in 2015, the company employs 44 individuals and generates an annual revenue of $5.3 million. Saptalis Pharmaceuticals specializes in the development, manufacturing, and commercialization of specialty generic prescription (Rx) and Over-The-Counter (OTC) products. They cater to the pharmaceutical market by focusing on niche areas with unique development challenges, high FDA market approval barriers, and lower competitive pressures. The company operates a 10,000 square foot R&D facility equipped with state-of-the-art technology for pharmaceutical product development, analytical method development, and validation. Their team comprises highly qualified pharmaceutical formulation scientists, analytical chemists, and regulatory affairs specialists dedicated to meeting current Good Manufacturing Practice (cGMP) requirements. For inquiries or further information, please visit Saptalis Pharmaceuticals' website at saptalis.com.